Sera Prognostics (SERA) Total Current Liabilities (2020 - 2026)
Sera Prognostics (SERA) posted Total Current Liabilities of $23.4 million for Q1 2026, down 3.18% on a QoQ basis from $24.2 million in Q4 2025, and little changed year-over-year from $23.4 million in Q1 2025.
Sera Prognostics (SERA) Total Current Liabilities (2020 - 2026) Analysis & Trends
Sera Prognostics' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $23.4 million for Q1 2026.
- Quarterly Total Current Liabilities changed 0.08% year-over-year to $23.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (changed 0.08% YoY) and the FY2025 annual result came in at $24.2 million, down 2.35% from the prior year.
- Total Current Liabilities was $23.4 million for Q1 2026 at Sera Prognostics, down from $24.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $24.8 million in Q4 2024 and bottomed at $6.9 million in Q1 2022.
- A 5-year average of $18.9 million and a median of $23.4 million in 2026 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 144.62% — and 2025, when it decreased 4.75%.
- Sera Prognostics' Total Current Liabilities stood at $15.5 million in 2022, then soared by 57.31% to $24.4 million in 2023, then increased by 1.34% to $24.8 million in 2024, then retreated by 2.35% to $24.2 million in 2025, then fell by 3.18% to $23.4 million in 2026.
- Business Quant data shows SERA's Total Current Liabilities at $23.4 million in Q1 2026, $24.2 million in Q4 2025, and $23.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 | 23.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.42 Mn |
| Dec 31, 2025 | 24.19 Mn |
| Sep 30, 2025 | 23.50 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 23.40 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | 24.18 Mn |
| Jun 30, 2024 | 24.76 Mn |
| Mar 31, 2024 | 24.57 Mn |
| Dec 31, 2023 | 24.44 Mn |
| Sep 30, 2023 | 13.55 Mn |
| Jun 30, 2023 | 14.18 Mn |
| Mar 31, 2023 | 13.80 Mn |
| Dec 31, 2022 | 15.54 Mn |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 8.41 Mn |
| Sep 30, 2021 | 3.54 Mn |
| Jun 30, 2021 | 3.23 Mn |